Back to Companies
Akebia Therapeutics, Inc.
AKBANasdaqCIK: 0001517022
Recent Form 4 activity at Akebia Therapeutics, Inc. (AKBA) spans 16 filings across 13 insiders (all of them on the sell side). Purchases total $86.6K against $654.0K in sales — heavily weighted toward selling, for net sales of $567.4K. Butler John P. is the most active by dollar volume, and the single largest transaction was $1.6M by Butler John P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$4.2M
Purchases
$86.6K
Sales
$654.0K
Unique Insiders
13
Recent Insider Trades
16 loaded
| Jul 1 | AKBA Akebia Therapeutics, Inc. | Ostrowski Erik | Insider | Sell | $62.2K |
| Jun 22 | AKBA Akebia Therapeutics, Inc. | ROGERS MICHAEL W | Insider | Grant | $54.7K |
| Jun 22 | AKBA Akebia Therapeutics, Inc. | Smith Cynthia | Insider | Grant | $54.7K |
| Jun 22 | AKBA Akebia Therapeutics, Inc. | FRIESON RON | Insider | Grant | $54.7K |
| Jun 22 | AKBA Akebia Therapeutics, Inc. | ZUMWALT LEANNE M | Insider | Grant | $54.7K |
| Jun 22 | AKBA Akebia Therapeutics, Inc. | ADAMS ADRIAN | Insider | Grant | $54.7K |
| Jun 22 | AKBA Akebia Therapeutics, Inc. | Wolf Myles | Insider | Grant | $54.7K |
| Apr 3 | AKBA Akebia Therapeutics, Inc. | Vickers Philip J. | Insider | Other | $0 |
| Mar 5 | AKBA Akebia Therapeutics, Inc. | Butler John P. | Insider | Buy | $86.6K |
| Feb 4 | AKBA Akebia Therapeutics, Inc. | Ostrowski Erik | Insider | Sell | $48.6K |
| Feb 4 | AKBA Akebia Therapeutics, Inc. | Malabre Richard C | Insider | Sell | $68.8K |
| Feb 4 | AKBA Akebia Therapeutics, Inc. | Butler John P. | Insider | Sell | $474.4K |
| Feb 3 | AKBA Akebia Therapeutics, Inc. | Rucci Carolyn M. | Insider | Grant | $380.7K |
| Feb 3 | AKBA Akebia Therapeutics, Inc. | Burke Steven Keith | Insider | Grant | $451.2K |
| Feb 3 | AKBA Akebia Therapeutics, Inc. | Butler John P. | Insider | Grant | $1.6M |
| Feb 3 | AKBA Akebia Therapeutics, Inc. | Grund Nicholas | Insider | Grant | $451.2K |
16 filings